Sunday, September 30, 2018 2:40:25 AM
those examples of large companies that are now having issues were the some of the biggest companies that lasted decades
some are now defunct due to circumstances beyond control and competition
competition could happen here also - big boys can crush little guy - Tucker for example
to compare amrn to apple is ridiculous imo
Apple invented personal computer - had a genius marketer running company
you think JT is Jobs - nice try - his CC sound elevator music
these guys are like wozniak and if wozniak ran apple they would have sold nothing - jobs created the hype and the vision - if we have a jobs ar amrn - lets go alone
also apple was on verge of disappearing from the planet until iMac and iPod - and they didn't;t invent the digital music player. The made it better because they were huge company that could market it - that is my point.
Great products die if you can't reach market quickly and efficiently.
I am good either way - i prefer being bought out.
I don't want to be diluted - how much money in your plan of GIA does AMRN need to raise to complete task. 1 billion?
Does anyone know on this board who wants to go it alone? how much money does it take to take any product from unknown to world wide recognition.
I agree vascepa should sell itself but that is not reality. They needed 70 million to run tv ads occasionally for a few months. sales didn't go up
Nov 10th is going to be huge - yes. But in sales competition can downplay many things no matter how good our product is. They will not stop working to sell their products.
I have been in sales for 30 years and sold many great products. I can tell you now the best TVs, Pagers, phones, vcd's jewelry clothes do not sell the most. It is products that companies can reach people.
That is why they pay so much for Super Bowl commercials.
I love Vascepa - i think it may be best frug of decade and is worth 10s of billions. But i don't care who sells it. I want my shares to go to as high as they can as fast as they can so i can take my profit and move on. I think everyone wants the same thing. I don't want them to undersell this - i want BP to overpay. And I think they will. IMO i think it is almost done. That is why every article coming out mentions buyout. where there is smoke, there is usually fire.
If we end up being a Celgene - i am fine with that - believe me. my brother bought that because a fellow doctor told him about when it was a buck or something - never sold til this day. Made him lots. But is like 14 years. He could make 10 times more in this by end of year - he has owned this for 2.5.(i like that scenario)
But if you had 10 million options and someone offered 100/share and you can become a billionaire by end of year. No one on this board - no one in world would turn that away. IMO JT won't either.
Based on all of thoughts that is fair bid right? - how can he refuse - IMO he can't. BB maybe price is 3:1. But there will be offer he can't refuse (i hope - Be a great christmas)
i an writing novel because don't know if i can respond because IHUB shuts me down after like 3 posts or something - but i am on everyone side here - this is drug and stock of a lifetime. I want us all to become filthy rich. AMRN deserves immense credit for giving the world such a thing. We deserve credit for persevering through down times and FUD
Just my thoughts - and I am not a merger and acquisition expert in biotech world as JL mentioned. I am just a very pro AMRN investor that owns stock at $1.78 and wants to sell at 100
Recent AMRN News
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:00:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:31:21 PM
- Amarin Chairman & CEO Issue Letter to Shareholders • GlobeNewswire Inc. • 01/22/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 10:31:04 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM